Lu Zhi Hao
Lu Zhi Hao — Chief Physician — GI Oncology — Peking University Cancer Hospital
Specialties
Immunotherapy, targeted therapy, and comprehensive treatment for esophageal cancer, gastric cancer, colorectal cancer, hepatobiliary and pancreatic tumors, and other digestive system tumors. Responsible for multiple clinical studies on digestive system tumors, especially targeted and immunotherapy for esophageal cancer.
Education
Ph.D. in Oncology from Peking University, Postdoctoral Fellow in Oncology at Johns Hopkins Hospital, USA
Professional Experience
Chief Physician of the Department of Gastrointestinal Oncology at Peking University Cancer Hospital, Professor, and Doctoral Supervisor. Postdoctoral fellow at Johns Hopkins Hospital, USA, recipient of the national high-level talent program, and Peking University Boya Young Scholar. Mainly engaged in the drug therapy and comprehensive treatment of gastrointestinal malignancies, including chemotherapy, molecular targeted therapy, and bioimmunotherapy for advanced esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, and others.
Professional Roles
Deputy Director of the Precision Cancer Treatment Committee of the Chinese Anti-Cancer Association, Director of the Esophageal Cancer Prevention and Treatment Committee of the Beijing Cancer Prevention and Treatment Society, among others